Peripheral arterial endothelial dysfunction of neurodegenerative diseases

Area of Science:

• Neuroscience
• Cardiovascular Science
• Medical Research

Background:

• Neurodegenerative diseases like ALS and Parkinson's (PD) may involve systemic vascular contributions.
• Endothelial function is crucial for vascular health and can be affected in various chronic conditions.

Purpose of the Study:

• To investigate peripheral arterial endothelial function in patients with amyotrophic lateral sclerosis (ALS), Parkinson's disease (PD), progressive supranuclear palsy (PSP), multiple system atrophy (MSA), and spinocerebellar ataxia (SCA).
• To compare endothelial function (Reactive Hyperemia Index - RHI) between neurodegenerative disease patients and healthy controls.
• To explore correlations between RHI and clinical/serological markers in ALS and PD.

Main Methods:

• Peripheral arterial tonometry was used to measure the Reactive Hyperemia Index (RHI).
• Serological data and clinical scales (FRS-R for ALS, H-Y for PD) were collected.
• (123)I-MIBG scintigraphy was used in PD patients.
• Comparisons were made between 302 normal controls and 537 patients across five neurodegenerative disease groups.

Main Results:

• Patients with ALS and PD exhibited significantly lower RHI compared to normal controls (p<0.01).
• RHI in ALS negatively correlated with serum triglycerides and insulin levels.
• RHI in PD negatively correlated with disease severity (H-Y scale) and positively with MIBG scintigraphy findings.

Conclusions:

• Peripheral arterial endothelial dysfunction is evident in ALS and PD.
• Distinct correlations suggest differing mechanisms of endothelial dysfunction in ALS (serum parameters) versus PD (disease severity, MIBG uptake).
• Endothelial function assessment may offer insights into the pathophysiology of specific neurodegenerative diseases.